Cannabis for rheumatic pain- hope or hype?
Despite the large number of patients utilizing cannabis for rheumatic pain there is a lack of clinical evidence for such use. A recent review has come out discussing the inconsistent results found amongst previous clinical trials that examine the effects of cannabis on patients with rheumatoid arthritis, fibromyalgia, and spinal pain. Previous studies have found a myriad of results, all uncertain when compared to each other or statistically analyzed despite the many online articles boasting about the benefits of cannabis for rheumatoid arthritis. Physicians of those suffering from chronic pain are advised to caution their patients and make them fully aware of the lack of clinical evidence, but also to push for clinical studies so that evidence can be provided as many continue to suffer.
It is important to note the “known side effects” of cannabis are different depending on the person and consumption method. The author of the featured piece highlights the dangerous side effects including psychosis and short-term dizziness or sleepiness. Various cannabinoids have different effects and act on different receptors, meaning that blanketing the entire plant with a warning label is often misleading. Patients should discuss cannabis use with their physicians and should be careful to mind which cannabinoids they aim to use and the method of consumption as that can greatly affect the potency and perceived effects. Consume cannabis responsibly and continue reading blogs like this one or other well-researched articles to remain fully aware of current findings.
The study is available for review or download here
View more studies like this in the CED Foundation Archive
To explore related information, click the keywords below: